Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Journal of Medicinal Chemistry|September 21, 2001
Synthesis and characterization of the antitumor activities of analogues of meridine, a marine pyridoacridine alkaloidE Delfourne, F Darro, N Bontemps-Subielos, et al.European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacinR Bruno, P Rosier, A Iliadis, et al.Journal of Sleep Research|March 25, 2000
Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the catJ S Lin, D Gervasoni, Y Hou, et al.Nature Physics|December 18, 2018
Imaging quantum fluctuations near criticalityA Kremen, H Khan, Y L Loh, et al.Clinical Pharmacology and Therapeutics|December 1, 1991
Influence of rifampin on the pharmacokinetics of pefloxacinG Humbert, I Brumpt, G Montay, et al.International Clinical Psychopharmacology|April 1, 1990
Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failureB Viron, M De Meyer, A Le Liboux, et al.Thrombosis and Haemostasis|April 1, 1995
Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism)F Collignon, A Frydman, H Caplain, et al.Thrombosis Research|March 1, 1993
Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitorL Bara, M F Bloch, D Zitoun, et al.Biomaterials|January 1, 1992
Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to ratsD V Bazile, C Ropert, P Huve, et al.European Journal of Clinical Pharmacology|January 1, 1976
Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertensionY A Weiss, M E Safar, C Chevillard, et al.Pageof 6